Orencia matches Humira
June 13, 2013Sales and Marketing AbbVie, Abbott, Humira, Orencia, RA
Bristol-Myers Squibb is hoping its biologic Orencia can grab a little more of the rheumatoid arthritis market after demonstrating non-inferiority …
Swiss comms agency archimed joins Fishawack
June 13, 2013Medical Communications archimed, fishawack
The Fishawack Group has acquired Swiss-based medical communications firm archimed in a deal that will expand both companies’ offerings. The …
‘Game-changing’ cancer database launched
June 13, 2013Medical Communications, Research and Development, Sales and Marketing Cancer, Department of Health, NHS
The Department of Health has unveiled a new system for co-ordinating cancer treatment which it hopes will save thousands of …
Paul Karpecki joins Freedom Meditech Scientific Advisory Board
June 13, 2013Manufacturing and Production, Research and Development, Sales and Marketing Freedom meditech
Medical device company Freedom Meditech has appointed Dr Paul Karpecki to its Scientific Advisory Board. Karpecki currently works in corneal …
Almac creates 229 jobs in Northern Ireland expansion
June 13, 2013Manufacturing and Production Almac, Ireland, laxative
Northern Ireland-based Almac is planning to invest almost £14 million in another expansion of its pharma development and manufacturing operation …
Pfizer wins $2.15 billion patent case
June 13, 2013Sales and Marketing Pfizer, Takeda, Teva, protonix
Pfizer and Takeda are to split $2.15 billion in damages from two generics manufacturers as a settlement for lost sales, …
NICE thumbs-up for Revolade
June 12, 2013Sales and Marketing
GlaxoSmithKline’s once-daily pill Revolade may be used to treat NHS patients who have a rare blood disorder, according to final …
Regulus names Stelios Papadopoulos as chairman
June 12, 2013Manufacturing and Production, Research and Development, Sales and Marketing Alnylam, Exelixis, Regulas
Biopharma firm Regulas Therapeutics has named Stelios Papadopoulos chairman of its Board of directors. Papadopoulos assumes the role from John …
Diabetes drug risks fuel transparency debate
June 12, 2013Research and Development, Sales and Marketing BMJ, Channel 4, all trials, diabetes, transaprency
A new investigation by Channel 4’s Dispatches and the British Medical Journal is demanding that all trial data be released …
French regulator probes Teva plant after patient death
June 12, 2013Manufacturing and Production Teva, furosemide, zopiclone
France’s medicines regulator has started an investigation into a manufacturing facility operated by generic firm Teva in the wake of …
ABPI: put more data in scorecards
June 12, 2013Sales and Marketing ABPI, NHS, scorecards
The ABPI has called on the NHS to include more new medicines in its innovation scorecard and to come up …
ABPI declares eye health services ‘unsustainable’
June 11, 2013Sales and Marketing ABPI, NHS England, POPI, eye health
The ABPI’s Pharmaceutical Ophthalmology Initiative (POPI) group has called for a major re-think in how eye services are delivered on the NHS.The …
GSK fires head of China research over data fraud
June 11, 2013Research and Development China, GSK, Jingwu Zang, MS, autoimmune
GlaxoSmithKline has dismissed its vice president of research in China in connection with ‘misrepresentation’ of research data.Jingwu Zang had been senior …
Charities invest £4.2m for London biosciences hub
June 11, 2013Research and Development, Sales and Marketing Biochemical Society, London hub, Society for General Microbiology, Society of Biology
A collective of five charitable societies have come together to create a new bioscience hub in central London. The offices …
Impax cuts staff at troubled California plant
June 11, 2013Manufacturing and Production FDA, Impax, Rytary
US generic drugmaker Impax Laboratories has said it plans to axe a tenth of its workforce and transfer production away …
Questcor hires Shire’s chief executive
June 11, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Questcor, Shire
Biopharma firm Questcor Pharmaceuticals has appointed the recently-retired chief executive of Shire to its Board of directors. Angus Russell …
Novartis works in MS switch
June 11, 2013Research and Development, Sales and Marketing MS, Novartis, gilenya
Novartis’ oral MS drug Gilenya has been found to help multiple sclerosis (MS) patients who switch to it after taking …
High cure rate for Boehringer HCV drug
June 11, 2013Research and Development, Sales and Marketing Boehringer Ingelheim, HCV
One of Boehringer Ingelheim’s pipeline drugs has achieved high response rates in patients with chronic genotype-1 hepatitis C virus (HCV) in …
AstraZeneca to pay up to $1.2 billion for Pearl
June 10, 2013Research and Development, Sales and Marketing AstraZeneca, COPD, pearl therapeutics
AstraZeneca is betting big on lung disease specialist Pearl Therapeutics as it looks to spend $1.2 billion to acquire the …
Manufacturing news in brief
June 10, 2013Manufacturing and Production Biological E Ltd, Hospira and Sotax Group, Schott Pharmaceutical Systems, Valneva SE
A round-up of recent developments in the pharma manufacturing sector, including facility updates from Valneva, Schott and Hospira, plus Sotax’s …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
